Cargando…

1973. A Meta-Analysis of the Effectiveness of LAIV4 and IIV against Influenza A/H3N2 Strains in Children 2–18 Years of Age During the 2016–2017 Season

BACKGROUND: The effectiveness of the quadrivalent live attenuated influenza vaccine (LAIV4) and inactivated influenza vaccines (IIV) has been evaluated in recent seasons using a number of different study designs (e.g., randomized controlled studies [RCT], cohort studies and test-negative case–contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallory, Raburn, Bandell, Allyn, Ambrose, Christopher S, Yu, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254534/ http://dx.doi.org/10.1093/ofid/ofy210.1629

Ejemplares similares

1401. Real-World Effectiveness of Inactivated and Live Attenuated Influenza Vaccines in Children During Three Recent Seasons: 2016–2019
por: Bandell, Allyn, et al.
Publicado: (2020)

Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children
por: Ang, Jann Catherine, et al.
Publicado: (2019)

Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink
por: Caspard, Herve, et al.
Publicado: (2018)

LB-2. Relative Effectiveness of aIIV3 versus IIV4 and HD-IIV3 In Preventing Influenza-Related Medical Encounters in Adults ≥65 Years of Age at High Risk for Influenza Complications During the U.S. 2017–2018 and 2018–2019 Influenza Seasons
por: Fischer, Lauren, et al.
Publicado: (2020)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines
por: Ambrose, Christopher S, et al.
Publicado: (2016)

Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis
por: Caspard, Herve, et al.
Publicado: (2017)

Internet Image Viewer (iiV)
por: Lee, Joel T, et al.
Publicado: (2008)

1395. Influenza B-Associated Pediatric Mortality in the US Between 2010 and 2019
por: Bandell, Allyn, et al.
Publicado: (2020)

Estimating the Incidence of Influenza at the State Level — Utah, 2016–17 and 2017–18 Influenza Seasons
por: Hughes, Michelle M., et al.
Publicado: (2019)

Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
por: Isakova-Sivak, Irina, et al.
Publicado: (2014)

Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season
por: Chabanon, Anne-Laure, et al.
Publicado: (2021)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2018)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
por: Turner, P. J., et al.
Publicado: (2019)

Update: Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine
por: Blanton, Lenee, et al.
Publicado: (2017)

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
por: Turner, Paul J., et al.
Publicado: (2020)

Complete genome sequence of invertebrate iridovirus IIV22A, a variant of IIV22, isolated originally from a blackfly larva
por: Piégu, Benoît, et al.
Publicado: (2014)

An Assessment of Pharmacy School Curricula in Florida and Inactivated Influenza Vaccine (IIV) Administration to Pregnant Women
por: Falope, Oluyemisi, et al.
Publicado: (2021)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
por: Sinnathamby, Mary A., et al.
Publicado: (2023)

Overview of seasonal influenza and recommended vaccine during the 2016/2017 season in Nepal
por: Jha, Bimalesh Kumar, et al.
Publicado: (2020)

Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years
por: Shi, Yunfeng, et al.
Publicado: (2023)

IIV-6 Inhibits NF-κB Responses in Drosophila
por: West, Cara, et al.
Publicado: (2019)

664 Influenza Vaccination in Chronically Ill Children: Taking a Closer Look at LAIV
por: Merckx, Joanna, et al.
Publicado: (2014)

Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons
por: Kawakami, Chiharu, et al.
Publicado: (2019)

Prediction of influenza vaccine effectiveness for the influenza season 2017/18 in the US
por: Paessler, Slobodan, et al.
Publicado: (2017)

Virological and Epidemiological Situation in the Influenza Epidemic Seasons 2016/2017 and 2017/2018 in Poland
por: Hallmann-Szelińska, E., et al.
Publicado: (2019)

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
por: Flannery, Brendan, et al.
Publicado: (2017)

Neurological Manifestations of Hospitalized Children with Influenza During the 2016–2017 Season
por: Rao, Suchitra, et al.
Publicado: (2017)

Intraindividual variability (IIV) in an animal model of ADHD - the Spontaneously Hypertensive Rat
por: Perry, Guy ML, et al.
Publicado: (2010)

Characteristics of hospitalizations with an influenza diagnosis, France, 2012‐2013 to 2016‐2017 influenza seasons
por: Pivette, Mathilde, et al.
Publicado: (2020)

Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season
por: Rondy, Marc, et al.
Publicado: (2017)

2610. Home Administration of Intranasal Live Attenuated Influenza Vaccine: A Review of Current Evidence and Potential for Meeting Vaccination Targets
por: Jhaveri, Ravi, et al.
Publicado: (2023)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom
por: Jackson, David, et al.
Publicado: (2020)

The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2‐18 years: Results of two phase 3 studies
por: Mallory, Raburn M., et al.
Publicado: (2018)

Infections with Influenza A/H3N2/ Subtype in Poland in the 2016/2017 Epidemic Season
por: Szymański, K., et al.
Publicado: (2018)

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

Current Opinion in LAIV: A Matter of Parent Virus Choice
por: Kiseleva, Irina
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uetcdtc6eincejd4hn96vh68q0